- Guidant Corp.
- Cordis Corp.
- Johnson & Johnson
- Novartis AG
- Boston Scientific Corp.
- Biosensors International Group Ltd.
- Occam International BV
- Gould Inc.
- Terumo Corp.
- Conor Medsystems LLC
- United States Surgical
- Covidien Ltd.
- Cook Group Inc.
- Medtronic PLC
- Angiotech Pharmaceuticals Inc.
- Devax Inc.
- Xtent Inc.
- The Foundry Inc.
- Guidant to co-promote Cordis's drug-eluting stent
- Guidant gets co-exclusive rights to Novartis antibiotic
- Cook licenses rights to paclitaxel from Angiotech
- Boston Scientific licenses paclitaxel rights from Angiotech
- Cook, Guidant develop drug-coated stents; terminated
- Guidant to license Biosensors' drug-eluting stents
- Terumo licenses Japanese rights to Biosensors' stent
- Devax stent will use Occam's drug and coating
- Xtent licenses Occam International BV's stent technology
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.